Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allogenic mesenchymal stem cells from adipose tissue are multipotent stromal cells isolated from the fat (adipose) tissue of healthy donors and administered to unrelated recipients. These cells possess regenerative, immunomodulatory, anti-inflammatory, and angiogenic properties. They can differentiate into various cell types (including osteocytes, chondrocytes, and adipocytes), secrete a range of paracrine factors that promote tissue repair and modulate immune responses, and support neovascularization in damaged tissues. Their therapeutic effects are mediated both by direct differentiation into target tissues and by secretion of bioactive molecules that influence local cellular environments. Allogenic AT-MSCs have been investigated for use in regenerative medicine applications such as wound healing (cutaneous wounds), autoimmune diseases (e.g., Crohn’s disease with perianal fistulas), radiation-induced injuries (acute radiation syndrome), bone/cartilage regeneration, vascular/metabolic diseases, neurodegenerative disorders, and immune-mediated conditions[1][2][3][5][6]. The use of allogeneic rather than autologous sources allows for off-the-shelf availability without requiring invasive harvesting procedures for each patient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on allogenic mesenchymal stem cells from adipose tissue.